Goldman Sachs
GH icon

Goldman Sachs’s Guardant Health GH Stock Holding History

Goldman Sachs’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-78,700
Closed -$6.15M – 5334
2019
Q4 		$6.15M Sell
78,700
-100,000
-56% -$7.21M ﹤0.01% 2792
2019
Q3 		$11.4M Sell
178,700
-13,600
-7% -$1.2M ﹤0.01% 2223
2019
Q2 		$16.6M Buy
192,300
+165,300
+612% +$12.6M ﹤0.01% 1994
2019
Q1 		$2.07M Buy
+27,000
New +$1.5M ﹤0.01% 3619

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs's GH Position: Q1 2026 in Review

Goldman Sachs increased its Guardant Health (GH) stake by 69% in Q1 2026, buying an estimated $182M and bringing the position to 4,435,839 shares worth $410M. The position accounts for 0.05% of the portfolio, ranked #402.

Goldman Sachs first reported a position in GH in Q4 2018 and has held it in 30 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Goldman Sachs held 4,435,839 shares of Guardant Health worth $410M as of Q1 2026.
  • Goldman Sachs bought 1,808,130 Guardant Health shares in Q1 2026, an estimated $182M.
  • Guardant Health made up 0.05% of Goldman Sachs's portfolio in Q1 2026, its #402 holding.
  • Goldman Sachs first reported a position in Guardant Health in Q4 2018 and has held it in 30 quarters since.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.